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The metabolic syndrome is a cluster of more or less related metabolic and cardiovascular derangements including visceral obesity, insulin
resistance, blood and tissue dislipidemia, high blood pressure and it is often associated with neuroendocrine and immunological dysregulations.
The aetiology of this syndrome is clinically highly relevant because it predisposes to life-threatening complications, such as Diabetes Mellitus,
kidney failure, cardiovascular disease, and certain types of cancer. Contributing factors include a sedentary life-style combined with increased
dietary fat intake and psychosocial stress. From a biological viewpoint, however, the metabolic syndrome can be considered as a maladaptive
consequence of an initially successful adaptation to high environmental demands. As opposed to pre-historic times — when environmental
demands were usually energy-costly (e.g., fight/flight/hunt) and nutritional resource often inadequate — energy-utilizing actions serve no longer
an optimal solution to deal with environmental demands of current human society. This paper describes the interactions between psychosocial
stress and nutrition and how these may affect emotional and metabolic components of the metabolic syndrome. A deeper understanding of these
interactions is necessary to come to effective treatment and prevention of the metabolic syndrome in the future.
© 2008 Elsevier B.V. All rights reserved.Keywords: Psychosocial stress; Obesity; Energy balance; Human; (Rat)Contents
1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 138
2. Thrift in demanding environments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 138
3. Neuroendocrinology of energy balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 139
3.1. Basic mechanisms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 139
3.2. Environmental context. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 139
4. Interactions between stress and nutrition . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140
5. Towards ecologically relevant models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 141
6. Dissociating emotional and metabolic aspects of stress and diet interactions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 141
7. Potential brain mechanisms subserving allostatic responses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143
8. Concluding remarks and future perspectives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143
Acknowledgement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 144
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 144⁎ Corresponding author. Tel.: +31 50 3632116 (or 2340); fax: +31 50 3632331.
E-mail address: gertjan.van.dijk@rug.nl (G. van Dijk).
0014-2999/$ - see front matter © 2008 Elsevier B.V. All rights reserved.
doi:10.1016/j.ejphar.2007.11.079
138 G. van Dijk, B. Buwalda / European Journal of Pharmacology 585 (2008) 137–1461. Introduction
The metabolic syndrome or “syndrome X” is a condition
characterized by a number of related metabolic and cardiovas-
cular abnormalities, including visceral obesity, insulin resis-
tance, glucose intolerance, hypertension, an athrogenic plasma
lipid profile, low-grade inflammatory state, and certain
neuroendocrine derangements including elevated levels of
“stress” hormones (Bjorntorp and Rosmond, 2000; Moller and
Kaufman, 2005). A critical issue for the health of individuals
who have several of these abnormalities in concert is that they
have a highly increased risk of developing debilitating diseases
including type-2 diabetes mellitus, cardiovascular complica-
tions, kidney failure, certain types of cancer and cognitive
impairments (WHO Technical Report series, 2002; James et al.,
2004; Marchesini et al., 2004; Yaffe et al., 2004). The
underlying causes of this syndrome are as yet unknown, but
factors related to a change in life-style have spurred the idea that
the metabolic syndrome is actually a life-style induced disease.
Despite the fact that clinical professionals and health care
organisations warn continuously for the devastating conse-
quences of an “unhealthy” life-style, recent surveys of the
World Health Organisation indicate that the prevalence of
humans with the metabolic syndrome is increasing at an
alarming rate (WHO Technical Report series, 2002). If no
serious break-through is reached soon, it is estimated that more
than half of our population will be affected within the near
future, and the costs associated with the treatment of the
associated illnesses become staggering to our society. While the
aetiology of the metabolic syndrome is relevant from a clinical
standpoint, it may be proposed that it is, in fact, a maladaptive
consequence of an initially successful adaptation to regulate
energy balance under conditions of increased environmental
demands. A thorough understanding of the underpinnings of the
metabolic syndrome would require insight in its original
adaptive nature as well. In this paper, we will discuss
neurobiological strategies of energy balance in demanding
environments and put these into a mechanistic framework of
how this could lead to obesity and metabolic derangements.
2. Thrift in demanding environments
Throughout the course of animal history, environmental
demands have continuously shaped species by natural selection
(Darwin, 1859). This has, among others, provided many species
including humans with highly efficient mechanisms to find,
ingest, and absorb nutrients. When absorbed nutrients exceed
immediate metabolic requirements, they can be packed into
storage tissues, and later released for metabolic purposes. These
features allow animal species to eat their food in bouts
interspaced by intermeal-intervals, and nonetheless maintain
long-term energy balance (Strubbe and van Dijk, 2002; Woods
et al., 2000). Ingesting nutritionally rich food items clearly has
the advantage for maintaining body energy stores most
optimally. It has been suggested that this enabled animals to
live through periods of famine and the most thrifty individuals
would have the highest survival chances. In 1962 James Neelproposed that humans surviving repeated periods of starvation
had “thrifty genes” which enabled them to do so by storing
excess nutrients more efficiently in their bodies in times of
plenty than others (Neel, 1962). This efficient storage capacity
would involve enhanced insulin responses during eating
behavior. The downside of this increased capacity to store
fuels is that it could lead to metabolic derangements such as
Diabetes Mellitus when these periods of famine are no longer
occurring (Neel, 1962). This “thrifty genotype” hypothesis has
attracted tremendous attention over the last decades, since it
held a promise to find the genetic underpinnings of — and
potential treatment strategies to combat— the current epidemic
of obesity and metabolic diseases (Cummings and Schwartz,
2003). A problem with this theory might be that specific
polymorphic “thrifty genes” have not been discovered on a large
scale in the obese population, and it has therefore been
questioned whether these exist at all (Speakman, 2006).
Moreover, past episodes of famine by lack of natural reserves
might have happened too infrequent to favour selection of
“thrifty genes” (as opposed to certain diseases) (Speakman,
2006). Although it is too early to call off the search for these
genes in our opinion, environmental factors might be equally or
even more prominently involved in determining how thrifty one
is, without necessarily altering the gene pool. A compelling case
has for instance been made for early perinatal programming of
life-long regulation of energy balance by Hales and Barker
(Hales and Barker, 1992). They hypothesized — and found
evidence — that poor foetal growth due to placental
dysfunctioning or malnutrition during pregnancy could propel
a “thrifty phenotype” and associated metabolic derangements
later in life in the offspring. The adaptive component (i.e.,
thriftiness) makes sense from a survival point of view. The
maladaptive component is a “catch-22” since maternal obesity
and type 2 Diabetes Mellitus obtained from poor foetal growth
could lead to relatively heavy newborns with also increased risk
for development of obesity and metabolic diseases later in life
(Dabelea and Pettitt, 2001; Hutcheon et al., 2006). In either
case, the magnitude by which potential “thrifty genes” (if they
exist) and/or perinatal/epigenetic programming events will
eventually lead to obesity and cardiovascular and metabolic
complications relies upon the environmental settings which
individuals will face later in life.
Frequently mentioned life-style factors that propel obesity and
the metabolic syndrome are increased intake of dietary fat and
sweeteners and sedentariness (WHO Technical Report series,
2002). Evidence is increasing, however, that also psychological
factors play a role in the development and propagation of obesity
and the metabolic syndrome (Bjorntorp, 1992; Brunner et al.,
2002). It can be imagined that over the course of animal
evolution, psychological stress had an intimate relationship with
nutrition as selection criteria for survival. It may for example be
expected that a relative mild food shortage easily changed the
relation between animals from co-consumers to competitors
fighting for these shrinking natural reserves, which finally affects
the relation with animals higher — up in the food chain (for
example due to increased exposure to predation) (Sweitzer,
1996). Subjects with the greatest ability to select under those
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fashion with effort to obtain it — had, and probably still do for
many wild life animals, the highest chance to live through these
stressful episodes. Especially finding dietary fat would qualify,
because it contains the most energy per unit weight among
nutrients, and therefore adds most to filling of reserve tissues
(Rolls, 2000). When nutritionally rich (and usually palatable)
food is abundant, but the environmental demands are changing
such that energy-utilizing actions (i.e., fight, flight, or hunt) are
no longer required, these biologically adaptive mechanisms can
easily become maladaptive, and trigger obesity and associated
metabolic derangements. Such a situation might very well apply
to humans in our society of plenty, in which a sedentary life-style
combined with a “rat-race” competition and high responsibilities
may put extremely high psychological pressures on individuals.
This idea seems confirmed by epidemiological studies in which
the metabolic syndrome was found most prevalent among
individuals under psychosocial pressure or chronic stress
(Bjorntorp, 1992; Brunner et al., 2002).
3. Neuroendocrinology of energy balance
3.1. Basic mechanisms
Before beginning to understand the mechanisms that may
drive the aetiology of the metabolic syndrome, we will first
discuss the mechanisms by which animals are capable of
maintaining energy balance. Several decades ago, Kennedy was
one of the first to recognize the stability of energy balance of
animals over most of their adult life (Kennedy, 1953). He
realized that the amount of energy an animal utilizes is almost
exactly matched by the amount of energy it consumes. Since the
smallest distortion of this match leads to alterations in the
amount of body fat, Kennedy hypothesized that the amount of
body fat is the regulated factor underlying energy balance
(Kennedy, 1953). Around the time Kennedy proposed this
mechanism, Hetherington and Ranson had already discovered
that lesions in the ventromedial hypothalamus caused rats to
become extremely hyperphagic and obese (Hetherington and
Ranson, 1983). Thus, it was proposed further that a factor
related to the amount of stored body fat would act in the
ventromedial hypothalamus where it would reduce food intake,
stimulate metabolism or both. This idea was reinforced in 1994
by Friedman and colleagues, who discovered that adipocytes
produce a hormone which they called “leptin” (coming from the
Greek word leptos meaning “thin”) (Zhang et al., 1994). Leptin
circulates in the blood stream roughly in proportion to body
adiposity, and enters the brain where it acts on specific leptin
receptors which, among other, are found, among other, in the
ventromediobasal part of the hypothalamus. Indeed, minute
infusion of leptin into the hypothalamus causes rodents (Van
Dijk, 2001) and primates (Tang-Christensen et al., 1999) to
reduce their food intake and stimulate their metabolism. The
mechanisms underlying this effect include leptin interacting
with neuropeptidergic neural pathways that arise from several
hypothalamic regions, and these pathways project to most other
regions in the brain (Schwartz et al., 2000). This negativefeedback loop involving leptin production and signalling is
working in humans as well since rare mutations in leptin
synthesis or leptin receptors result in extreme forms of obesity
(Farooqi and O'Rahilly, 2004).
There are many other factors that are integral to the above-
mentioned regulation. When an animal senses food, this
information is processed in the brain and the animal can
approach it, or hunt it down, and ingest it. Its decision to do so
obviously depends upon its history. Thus, when an animal has
finished a meal just prior to seeing the next food item, signals
related to the filling of the gastrointestinal tract (Dockray, 2004)
and the metabolic status of the liver (Scharrer, 1999) are
conveyed via afferents which connect these organs to the
brainstem. In turn, regions in the brainstem (including the
nucleus of the solitary tract, area postrema, locus coeruleus, and
the parabrachial nucleus) relay this information and pass it on to
the hypothalamus and limbic structures, and finalize it into a
sensation or perception of satiety in higher brain regions, and the
animal may decide not to eat it (Berthoud, 2004). However, when
the animal remembers from other occasions that the palatability
of this next food item is very high, satiety can be overruled by a
sensation of reward which the animal gets (or “anticipates” to
get) from ingesting it (Berthoud, 2004; Schultz, 2002). The
animal will eat it, despite the fact it is satiated. The mechanisms
underlying reward include regions in the fore- and midbrain, such
as the ventral tegmental area/substantia nigra and the nucleus
accumbens. It is currently believed that both gastrointestinal/
hepatic satiety and nutritional reward signals are regulated by
leptin (Figlewicz, 2003; Matson et al., 2000). Besides regulating
energy balance, evidence is increasing that leptin action in the
brain has a major effect on neuroendocrine/autonomic outflow
(Van Dijk et al., 1997; Van Dijk et al., 2003). Indeed, the above-
mentioned neuropeptidergic pathways project to the preganglio-
nics of the autonomic nervous system, and they regulate the
activity of several neuroendocrine axes (Elmquist, 2001). This
way, leptin acting in the brain can regulate peripheral fuel fluxes
in and between organs (Van Dijk et al., 2003). When central
leptin action is blocked, this not only leads to increased filling of
adipose tissue (i.e., through increased food intake and reduced
metabolism), but it also leads to overflow of fat fuels from
adipose tissue to non-adipose organs such as the liver, muscle,
and pancreas (Cohen et al., 2001). Since the intracellular fatty
acid level in insulin sensitive organs (such as the liver and
muscle) directly interferes with insulin signalling, it is most likely
that this latter mechanism is the prime culprit underlying whole
body insulin resistance and dyslipidemia (Boden and Shulman,
2002). Whereas the mechanisms behind this phenomenon are
still not entirely clear, a teleological explanation may be that
filling of extra-adipose tissue is simply enlarging the total storage
capacity of fat fuels in the body. This might make sense from an
evolutionary point of view, as has been pointed out before by
Neel (1962).
3.2. Environmental context
Besides regulating energy balance and fuel homeostasis,
another function of the brain is, of course, to protect animals
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tion regarding (potentially) dangerous situations or threats in the
environment is processed in limbic brain structures (including
the hippocampus, the amygdala and the prefrontal cortex),
which finally leads to the sensation of “fear”. Among the
emotions, fear is probably the best studied (LeDoux, 2003;
McEwen, 2003; Miller et al., 2005), and is highly relevant in
acute situations like threat of predation or social conflict. When
facing immediate danger, an animal can defend itself or run. In
either case, a “stress response” is initiated by the brain which
serves to alarm the body in an anticipatory fashion for its
internal defence. The initiation of this response occurs at the
level of the hypothalamus, where neuronal cell bodies release
corticotropin-releasing hormone (CRH) which eventually leads
to the stimulation of glucocorticoid production (cortisol in
primates, and corticosterone in rodents) and epinephrine release
from the adrenal gland (Sawchenko et al., 1993). These
hormones activate the cardiovascular system and respiration,
serve to mobilize energy to muscles, and they set immunolo-
gical priorities (Bohus et al., 1993; Pollard, 1997). Low-priority
functions like gastrointestinal functioning and reproduction are
decreased under those conditions. Glucocorticoids also feed-
back to the brain where they can inhibit the neural systems
where the stress response was initiated (Young and Vazquez,
1996). On the other hand, glucocorticoids improve memory
functions (Roozendaal and McGaugh, 1997), ensuring that
future threats are detected as early as possible, and can be coped
with effectively (i.e., avoided or passively/actively dealt with).
In 1865, Claude Bernard published his “Introduction à
l'étude de la médecine expérimentale” in which he realized that
maintenance of a stable milieu inside the body in the face of
external changes was a necessary condition for a free life
(Bernard, 1865). This concept was further outlined by Walter B.
Cannon, who introduced the term “homeostasis” (“homeo”
means “same”), and popularized it further in the early twentieth
century (Cannon, 1932). The concept of homeostasis is
nowadays largely used by scientists who study the regulation
of fuel fluxes in the body and the capacity of the body to
maintain energy balance (see previous paragraph) mainly
through negative feedback-regulatory mechanisms. Although
there is still a lot of debate around this subject, the ability of the
body to respond to threats in an anticipatory fashion in order to
keep the “internal milieu” stable has been termed allostasis
(“allos” and “stasis” are Greek words for “change” and
“stable”), and is used since the early 1980s. It is more complete
than the term homeostasis. The classic image of an allostasis
mechanism is that of a predator running after its prey. Both
animals allow deliberate disruptions of “fuel homeostasis” on
the short term to enable these fight/flight responses. In his book
“The end of stress as we know it”, McEwen points out that the
situations that ignite stress responses nowadays are increasingly
ones for which neither fight nor flight is an option. These
stressors are often psychological in nature (e.g., working for an
overbearing boss, or caring for a family member who is
seriously ill, etc). As a result, the stress response can become
more prevalent and stronger, or even become chronic.
Frequently or continuously elevated plasma levels of epinephr-ine and the resulting surges in blood pressure can damage the
blood vessels of heart and brain, and eventually lead to
atherosclerosis, a major risk factor for heart attack and stroke
(McEwen and Lasley, 2002). Excessive and prolonged amounts
of circulating glucocorticoids impair the immune system,
reduce insulin action, and cause visceral fat storage to
accumulate. Within the brain, high levels of glucocorticoids
can cause damage to vulnerable brain structures such as the
hippocampus (Sapolsky, 1996). The damage that the allostatic
response causes when stressors are inescapable is termed
“allostatic load”, and this resembles, in fact, many aspects of the
metabolic syndrome (Korte et al., 2005; McEwen and Lasley,
2002).
4. Interactions between stress and nutrition
Current knowledge of the neurobiology of stress and
regulation of energy balance has finally advanced to a level to
allow an integration of the two. The systems that serve the
regulation of energy balance are strongly interconnected to the
ones that regulate the allostatic responses to environmental
demands. For example, Dallman and colleagues have pointed
out that glucocorticoids are key in shifting fuel homeostasis
from a fed to a fasting state (Akana et al., 1994). This shift
would be necessary to maintain fuel homeostasis during fasting.
When food becomes available, glucocorticoids increase feeding
behavior (Tempel et al., 1992), thereby offsetting its own
increase. A similar mechanism involving glucocorticoids could
also be active during stress situation as pointed out earlier.
Evidence is available that the effect of glucocorticoids is
mediated by a number of neural pathways in the brain that serve
the effects of leptin as well, but in opposing directions
(Jeanrenaud and Rohner-Jeanrenaud, 2000). In addition to
increased food intake, also several signs of the metabolic
syndrome are found upon chronic central glucocorticoid
administration (Jeanrenaud and Rohner-Jeanrenaud, 2000), an
effect that is consistent with certain diseases characterized by
hypersecretion (or action) of glucocorticoids (Chrousos, 2000).
Leptin is more efficacious to reduce feeding behavior in animals
without adrenals than in sham operated animals (Drazen et al.,
2003). This increased efficacy is counteracted by treatment of
dexamethasone, a synthetic glucocorticoid (Drazen et al.,
2003). Finally, the obesity resulting from leptin deficiency, as
well as most other monogenetic or central lesion-induced
(Dallman et al., 1993) models of obesity can be corrected when
the adrenal glands of obese animals are removed.
As a whole, these interactions seem to indicate that a high
glucocorticoid/leptin signalling ratio might underlie the aetiol-
ogy of the metabolic syndrome (Zakrzewska et al., 1997).
However, do these interactions also underlie the metabolic
syndrome in ecologically relevant situations?
At this moment, several laboratories world-wide are
concerned with the study of the aetiology of the metabolic
syndrome resulting from allostatic mechanisms. In general,
investigations are conducted using genetically selected/mod-
ified rodents in laboratory conditions or in humans in clinical
settings. Although there is no doubt that this work has greatly
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balance and neuroendocrine regulation of metabolism and
ingestive behavior, these studies have not been very instru-
mental in elucidating the true underpinnings of the metabolic
syndrome. A major problem of revealing these underpinnings is
that they become obscured and untraceable as soon as the
metabolic syndrome becomes a fact. In a new approach, we
have recently initiated investigation of psychosocial pressure on
aetiology of the metabolic syndrome in genetically normal rats.
Our laboratory embraces a model of psychosocial stress in
which rats are subjected to social defeat on 2–3 occasions by a
dominant rat in a resident–intruder paradigm (Buwalda et al.,
2001; Koolhaas et al., 1997). Following social defeat, stressed
rats feeding a healthy carbohydrate-rich diet developed transient
loss of appetite, behavioral inactivity and fever, and temporarily
or chronically lose body weight (Koolhaas et al., 1997). They
showed long-term deterioration of mood (Meerlo et al., 1996),
and displayed a reduced performance in a so-called novel object
recognition paradigm (van Dijk and Buwalda, unpublished
observation). Upon reintroduction with the dominant rat by
which they were defeated previously, the rats responded with
strong conditioned behavioral and neuroendocrine responses
(van Dijk and Buwalda, unpublished observation). Although
psychosocial stress is clearly a heavy stressor, and causes
profound allostatic responses, the rats feeding a “healthy” diet
did not show signs of the metabolic syndrome, as evidenced by
similar plasma insulin responses to intravenously infused
glucose and plasma adiponectin levels as compared to
undefeated controls. A different picture emerged, however,
when rats undergoing psychosocial stress were feeding a high-
fat diet. In this case, psychosocial stress caused a profound
lowering of plasma adiponectin levels (i.e., which is a strong
indication for development of type-II diabetes mellitus in
humans (Hotta et al., 2000), and a markedly increased plasma
insulin response following an intravenous glucose challenge,
indicating insulin resistance. None of these effects were
observed in rats feeding the same high-fat, but had not
undergone social defeat stress (van Dijk and Buwalda,
unpublished observation). These data therefore suggest that
psychosocial stress leads to characteristics of the metabolic
syndrome provided that these rats are feeding an “unhealthy”
high-fat diet.
5. Towards ecologically relevant models
The use of psychosocial stress in the resident–intruder
paradigm has the advantage for the investigator to exert
reasonable experimental control, and as explained above, this
can be an excellent asset to the study of the aetiology of the
metabolic syndrome. To investigate these interactions in a
model with a higher face-validity for the human situation,
interactions between psychosocial stress and dietary fat on
energy balance and the aetiology of the metabolic syndrome can
be investigated in colony-housed rats. Psychosocial stress is
common in many animal species living in colonies and typically
results from competition for resources such as space, access to a
reproductive partner, food or water. A number of animal modelshave been developed to capitalize on the tendency of different
species to form social hierarchies when housed in groups,
including rats (Blanchard and Blanchard, 1990; Fokkema et al.,
1995; Tamashiro et al., 2004), mice (Ely and Henry, 1978; Van
Oortmerssen, 1971), and non-human primates (Barrett et al.,
2002). Establishing and maintaining dominance in a group
setting is psychologically and physically stressful for all parties,
including both the dominant and the subordinate animals.
Furthermore, since animals are group-housed for extended
periods of time, the members of the group are continuously
exposed to stress as opposed to intermittent acute exposures as
mentioned in the resident–intruder paradigm. A potential
problem with studying colonies is that the experimental control
of the investigator is reduced. Sakai and colleagues partly
resolved this issue by studying colony-housed rats kept in semi-
natural “visible burrows” (Tamashiro et al., 2004). Briefly, the
visible burrow system (VBS) includes a large surface area, to
which smaller chambers are connected by a number of tunnels.
It involves housing of mixed-gender (typically four or five
males and two females) groups of rats in a semi-naturalistic
burrow environment continuously for 14 days or longer. Within
a few days after colony formation, a dominance hierarchy forms
among the males of the group resulting in 1 dominant and 3–4
subordinate animals.
Controls are single males pair-housed with a single female.
The VBS model has the advantage of forming stable hierarchies
over time: i.e., it has been used for investigating the effects of
single as well as repeated episodes of exposures to psychosocial
stress (Tamashiro et al., 2005). There is no indication that the
animals habituate to VBS housing conditions as indicated by the
persistence of significant stress-induced behavioral and phy-
siological changes that occur during VBS housing. These
include decreased body weight and elevated basal glucocorti-
coid levels in subordinate males (Tamashiro et al., 2004).
Interestingly, subordinate animals rapidly regained body
weight during a recovery phase (outside the VBS), but,
compared to dominant animals, they mainly did so by
significantly elevating visceral fat content. The latter effects
were stronger when animals were feeding a high-fat diet
(Tamashiro et al., 2006).
6. Dissociating emotional and metabolic aspects of stress
and diet interactions
The data of Sakai and colleagues point out that metabolic
derangements might particularly develop in the emotional
recovery phase following psychosocial stress, with dietary fat
and sedentariness as propagating factors. Our studies using the
resident–intruder paradigm may also involve a comparable
recovery component which could act independent of the
metabolic consequences of stress and dietary fat. In fact, in
contrast to the deleterious permissive effects of feeding a high-
fat diet on the development of the metabolic syndrome in
psychosocially stressed rats, we unexpectedly observed that a
number of other “negative” effects of the psychosocial stress
were markedly attenuated by feeding the high-fat diet. Thus,
psychosocially stressed rats feeding the high-fat diet appeared
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being reintroduced with the dominant rat by which they were
previously defeated than psychosocially stressed rats feeding
the high-carbohydrate chow. One potential mechanism through
which feeding a high-fat diet mediates these effects, is that it is
“comforting” for them. This idea has been proposed by Dallman
and colleagues (Pecoraro et al., 2005), who hypothesized a role
for glucocorticoids in these effects. While this certainly can be a
potential mechanism, experiments of the group of Dallman do
not point to dissociation between the types of nutrients; i.e., rats
would find a solution to reduce their emotional allostatic load in
any nutrient with a higher palatability, including fats and sugars.
Indeed, when supplied in solution, restrained-stressed rats
(Pecoraro et al., 2005) can ingest sucrose avidly. Our data point
to a more specific role of fats in alleviating emotional stress, and
this in agreement with the findings of Levin et al. (2000),
showing reduced fear and stress responses in diet-induced obese
rats. In addition, our psychosocially stressed rats feeding a high-
fat diet performed significantly better in a behavioral test, in
which their performance was assessed to identify a novel object.
Finally, psychosocially stressed rats feeding the high-carbohy-
drate diet showed a down-regulation of the hypothermic
response to the serotonergic (5HT) agonist, 8-OH-DPAT,
which is clinically used as a marker for deterioration of mood
(Lesch, 1991). This down-regulation was not observed in
psychosocially stressed rats feeding the high-fat diet (Buwalda
et al., 2001). Thus, despite the fact that rats feeding the high-fat
diet were on a fast lane towards the development of the
metabolic syndrome, they appeared to handle the psychosocial
stress better on cognitive and affective fronts. In this event, the
concept of allostasis may come to mind again and may provide aFig. 1. Models of interaction between high-fat feeding and environmental threat
environmental threat is possible, and quick relief is found. High-fat feeding serves
environment does not allow an active strategy (such as during inescapable psychoso
and metabolic allostatic loads are lost. C) This situation becomes worse if a passive st
The emotional and metabolic allostatic loads are hypothesized to reinforce one anotconceptual framework. On the one side, these findings might be
explained to indicate that high-fat feeding reduces the emotional
allostatic load, and simultaneously increases the metabolic
allostatic load following psychosocial stress on the other side.
These simultaneous effects of a high-fat diet on emotional
and metabolic allostatic loads have a number of implications.
First of all, when a high-fat diet causes animals to cope easier
with stress because it reduces the animal's emotional allostatic
load, it can be imagined that rats as well as humans “like” or
“want” (Berridge, 2004) to ingest increasing amounts of fat
under conditions of elevated environmental demands. There are
a few reports that indeed point to this effect (Oliver et al., 2000;
Wardle et al., 2000; La Fleur et al., 2005). At this point, it is very
important to consider the type of environmental demand or
stress. If the environment allows an active coping strategy
which drains a lot of energy (such as during fight/flight/or hunt),
the metabolic allostatic load will not easily develop, even if the
animal would ingest a high-fat diet (see Fig. 1A). However, if
the environment does not permit an active coping strategy (such
as during inescapable psychosocial stress) and thus no drain of
energy takes place, there is no break on the development of the
metabolic allostatic load (Fig. 1B).
In addition, threats faced by an active coping strategy
generally take less time to end than those that are faced by
passive coping strategies, and lasting threats could add to the
emotional allostatic load more easily (Fig. 1B). The worst-case
scenario is the situation in which the threat becomes chronic,
and cannot be off-set by the passive coping strategy (Fig. 1C). If
food is available in unlimited quantity and choice, it is
conceivable that individuals crave for “comforting” food
items, and dietary fat may represent an alternative default. A) The course of events when an active strategy (fight/flight/hunt) to the
as a high energy source to meet metabolically demanding events. B) When the
cial stress). No quick relief is found. Note that the negative breaks on emotional
rategy becomes a static state, and environmental threats can not be relieved at all.
her.
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intake adds further to metabolic allostatic load, etc. In this way,
all breaks on the system are lost and a pathological vicious
circle is initiated. We propose that emotional and metabolic
allostatic loads start adding on to each other, potentially due to
intracellular wear and tear of metabolic machinery, which
eventually will lead to all characteristics of the metabolic
syndrome, including deterioration of mood.
7. Potential brain mechanisms subserving allostatic
responses
As pointed out above, high-fat feeding and psychosocial
stress increase the metabolic allostatic load in rats, and there is
growing evidence that this can also occur in humans (Brunner et
al., 2002; Vitaliano et al., 2002). It is assumed that these
interactions are ignited within the brain and are reflected in the
peripheral body, and these latter effects eventually impose upon
the brain again. One potential mechanism underlying the
development of the metabolic syndrome may be a reduction of
leptin signalling in the brain. Indeed, we have previously shown
that central leptin insensitivity predicts development of several
characteristics of the metabolic syndrome in normal rats (Van
Dijk et al., 2005). Then how could feeding a high-fat diet result
in a decline of leptin signalling in psychosocially stressed
(genetically normal) animals, and at the same time be protective
against deterioration of mood?
As mentioned earlier, pathways responsible for brain leptin
signalling include several neuropeptide systems that arise form
hypothalamic nuclei (Schwartz et al., 2000). Among these is the
brain melanocortin system. Gene expression of proopiomelano-
cortin (POMC)— from which the melanocortin receptor agonist
alpha-melanocyte stimulating hormone (MSH) is spliced post-
translationally— is stimulated by leptin (Van Dijk et al., 1999),
and treatment with a specific melanocortin receptor blocker can
prevent leptin's anorexigenic action (Adage et al., 2001; Seeley
et al., 1997). While obesity in animal models of obesity via leptin
resistance can normally be corrected by removing the adrenals of
the obese animals (Jeanrenaud and Rohner-Jeanrenaud, 2000;
Zakrzewska et al., 1997), obesity and metabolic syndrome that
follows from a disturbance in brain melanocortin system seems
to be an exception to this rule (Yaswen et al., 1999). Mice with
targeted deletion of POMC are obese, but do not have adrenals
(Challis et al., 2004). The latter is probably due to the fact that
POMC expression in the pituitary, which normally gives rise to
ACTH production, is required for adrenal development (Karpac
et al., 2007). Because psychosocially stressed rats feeding the
high-fat diet initially appeared to increase their metabolic
allostatic load without lasting elevated glucocorticoid levels (in
fact the reactivity of the HPA axis was reduced in our
psychosocially stressed rats feeding the high-fat diet upon
reintroduction with the dominant rat), there could be a potential
role for diminished brain melanocortin activity in the initial
aetiology of the metabolic syndrome in high-fat feeding rats
subjected to psychosocial stress.
There are a number of observations that back up this idea.
First of all, we have previously observed that chronic centralpharmacological blockade of melanocortin receptors in rats
increases visceral adiposity in these animals, and that these
effects are markedly enhanced upon feeding a high-fat diet (on
which they became significantly more hyperphagic) relative to
those feeding a high-carbohydrate diet (Morens et al., 2005).
This effect of the high-fat diet was not seen in animals not
infused with the melanocortin receptor antagonist. Since many
others have shown that increased high-fat diet intake reduces
POMC gene expression in the arcuate nucleus — see e.g.
(Huang et al., 2004; Parton et al., 2007) — this situation could
become intrinsically reinforcing (Adan and van Dijk, 2006).
This effect, however, probably depends on glucocorticoid
action since mice that lack 11β-hydroxysteroid dehydrogenase
Type 1 (the catalyzing enzyme for regenerating active
intracellular glucocorticoids) do not show reduced POMC
expression when subjected to high-fat feeding (Densmore et al.,
2006). Thus, although we stated that obesity and the metabolic
syndrome could result from POMC deficiency independent of
glucocorticoid action, this does not mean that glucocorticoids
may not be required for the effect of high-fat feeding to lower
the activity of the POMC neuron. While acute stress (which
leads to increased levels of glucocorticoids) is able to increase
arcuate nucleus POMC expression (Larsen and Mau, 1994), we
propose that this increase is transient, and eventually becomes
reduced below basal levels when this is associated with feeding
a high-fat diet. A lowering of POMC expression and thus a
subsequent reduction of brain melanocortin activity may have
two consequences, namely it would induce hyperinsulinemia
and thriftiness (Fan et al., 2000), and, secondly, animals would
lighten up emotionally (Kokare et al., 2005). In fact, reduced
brain melanocortin activity has been suggested to be anti-
depressive (Chaki and Okubo, 2007) and to reduce the effects of
stress on affective (Liu et al., 2007) and ingestive (Vergoni et al.,
1999) behaviors.
Like mice, humans bearing a genetic mutation causing
POMC deficiency are hypocortisolemic and obese as well
(Krude et al., 2003). Together with mutations in the melano-
cortin-4 receptor, they represent the most common forms of
monogenic obesity known today (Farooqi and O'Rahilly, 2004;
Farooqi and O'Rahilly, 2005). When polymorphisms in a
certain system are far more widespread than those in other
systems, but underlie seemingly comparable trait characteristics
(in this case obesity), there could be a beneficial side effect
associated with these frequent polymorphisms. In the case of the
brain melanocortin system, these beneficial side effect might be
found on the emotional front.
8. Concluding remarks and future perspectives
It was mentioned in the beginning of this paper that the
metabolic syndrome may be a maladaptive consequence of an
initially adaptive strategy to deal with environmental demands.
These demands probably included frequent episodes of famine
and psychosocial threats. Given the intimate relation of these
factors such that they could have created common selection
criteria for survival over the course of animal history, it is no
surprise that the neurobiological mechanisms to deal with
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behavior, ingesting energy dense food, and large nutrient
storage capacity in body depots) are highly linked. While it is
not surprising on the same grounds that a relationship exists
between these factors in the development of the maladaptive
component (i.e., the metabolic syndrome), the precise neuro-
biological underpinnings are as yet still unsure. In our view this
has partly to do with the methodologies used to investigate these
underpinnings. Most laboratories concerned with the study of
the aetiology of the metabolic syndrome utilize genetically
selected/modified rodents in laboratory conditions without
social interaction. Since it is becoming clear that “psychosocial
stress” is an important component in the development of the
metabolic syndrome, it is important to consider experimental
paradigms that take account of these issues. Thus, it is therefore
necessary to focus on the development of the metabolic
syndrome in ecologically relevant animal models which highly
translates to the human situation. These conditions are
characterized by 1) ad libitum availability of palatable food,
2) low physical activity, and 3) a highly demanding environ-
ment in which psychosocial stressors are most common. How
could we use this knowledge to prevent the aetiology of the
metabolic syndrome? It is evident that minimizing nutrient
intake, and particularly that of fat, would alleviate some of these
effects, but a reduction in food intake in an attempt to lose body
weight and metabolic derangements leads to compensatory
metabolic adjustments that minimize weight loss (Leibel et al.,
1995). In addition, drastic reduction in fat consumption might
even be considered not to be useful in this event since the model
represented in Fig. 1 predicts that relief of emotional allostatic
load by dietary fat intake could represent some form of comfort
control. It seems more plausible based on Fig. 1 that losing
energy through exercise, or other metabolically demanding
events (Chakravarthy and Booth, 2004) is a more successful
way to reduce metabolic allostatic load. Moreover, regular
exercise improves mood and could be helpful in coping with
stress (Anthony, 1991). Another form of metabolic relief could
be provided by subjecting animals to a diet which contain
elevated amounts of poly-unsaturated fatty acids (PUFAs). As
opposed to saturated fatty acids, which form the bulk of fat
source of the high-fat diet which we provide to the animals in
our studies, poly-unsaturated fatty acids are known to stimulate
the enzymatic machinery involved in the oxidation pathways of
fatty acids (Clarke, 2001). Although the underlying mechan-
isms are not entirely clear, evidence is becoming available that
the brain plays a role in the effects of exercise (Scheurink et al.,
1999) and of elevated dietary poly-unsaturated fatty acid levels
(Wang et al., 2002) on energy balance, and probably include
systems downstream from leptin signalling. We are currently
assessing these treatment strategies to investigate whether they
can prevent the development of the metabolic syndrome in
psychosocially stressed rats feeding a high-fat diet, and which
central neural pathways can be assigned to contribute to these
effects. Effective drugs that tie into the pathways through which
exercise and dietary poly-unsaturated fatty acids-enrichment
have beneficial effects in curing the metabolic syndrome could
be used as potential treatment modalities as well. Above allthese options, it would be most optimal to find a societal
solution for our “stress” problem, and — given the epigenetic
windows of metabolic programming — this should be
considered already at a very young age (McEwen, 2000).
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